Diabetologia (2011) 54:264959
As a long-standing first-line treatment for type 2 diabetes, it is both safe and effective
The Magnolia Approach: Not an Automatic Upgrade For patients transitioning from semaglutide after a plateau, the first question Dr
Microvascular effects One emerging hypothesis involves changes to small blood vessels in the skin
Symptoms and Warning Signs to Watch For Patients who start Foundayo should contact a clinician if they experience: Persistent nausea, vomiting, or severe abdominal pain Signs of low blood sugar if also taking diabetes medications Changes in vision Racing or pounding heartbeat Any new or unusual symptoms Rare but serious risks associated with GLP-1 medications include pancreatitis, gallbladder problems, and kidney injury related to dehydration from vomiting
Further, 62.4 percent of participants treated with the highest dose of tirzepatide achieved an A1C of less than 5.7 percent